Evidence map›Paper›PMID 27365992›Full record

ArticlePharmacognosy research

Evaluating the Anticancer Potential of Ethanolic Gall Extract of Terminalia chebula (Gaertn.) Retz. (Combretaceae).

B E Ravi Shankara, Y L Ramachandra, S Sundara Rajan, P S Sujan Ganapathy, Nagendra Sastry Yarla, S A Richard, Bhadrapura Lakkappa Dhananjaya

Abstract read
In one paragraph

Article in Pharmacognosy research. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. From traditional remedy toFrontiers in pharmacology · 2026
    Article
  2. Review
  3. Article
  4. Article
  5. The therapeutic mechanism ofFrontiers in veterinary science · 2023
    Article
  6. Review
  7. Article
  8. Phyto-Mediated Synthesis of Silver Nanoparticles UsingMolecules (Basel, Switzerland) · 2020
    Article
  9. Pharmaceuticals (Basel, Switzerland) · 2020
    Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

B E Ravi ShankaraDepartment of Chemistry, School of Graduate Studies, Jain University, Chamrajpet, Bengaluru, Karnataka, India; Research Unit in Vrukshayurveda, A Division of Centre for Advanced Studies in Biosciences, Jain University, Chamrajpet, Bengaluru, Karnataka, India; Department of PG Studies and Research in Biotechnology, Kuvempu University, Shankaraghatta, Mysore, Karnataka, India.
Y L RamachandraDepartment of PG Studies and Research in Biotechnology, Kuvempu University, Shankaraghatta, Mysore, Karnataka, India.
S Sundara RajanDepartment of PG Studies and Research in Biotechnology, Kuvempu University, Shankaraghatta, Mysore, Karnataka, India.
P S Sujan GanapathyResearch Unit in Vrukshayurveda, A Division of Centre for Advanced Studies in Biosciences, Jain University, Chamrajpet, Bengaluru, Karnataka, India.
Nagendra Sastry YarlaDepartment of Biochemistry, Institute of Science, GITAM University, Visakhapatnam, Andhra Pradesh, India.
S A RichardDepartment of Biochemistry, University of Mysore, Mysore, Karnataka, India.
Bhadrapura Lakkappa DhananjayaToxinology/Toxicology and Drug Discovery Unit, Centre for Emerging Technologies, Jain University, Ramanagara, Karnataka, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

unlabelledPlants have been an important source for discovery of anticancer compounds. With the current decline in the number of new molecular entities from the pharmaceutical industry, novel anticancer agents are being sought from traditional medicines; therefore the anticancer efficacy of many plants that are used in traditional medicine is yet to be verified. The objective of the study was to evaluate the cytotoxic potential of ethanolic leaf gall extract of Terminalia chebula are evaluated against buffalo rat liver 3A, MCF-7 (Human mammary gland adenocarcinoma) and A-549 (Human lung cancer) cell lines. The cytotoxic effect of the ethanolic extract was evaluated by MTT assay. The extract was potent and effective in inducing cytotoxic effects in all the cell lines with an IC50 value of 305.18 ± 1.7 μg/mL, 643.13 ± 4.2 μg/mL, and 208.16 ± 3.7 μ/mL, respectively. The extract was more effective against A549 cell lines when compared to others. The presences of phenolics, triterpenoids, and flavonoids were identified in the extract. The extract showed total phenolic and flavonoid content of 478 ± 2.2 mg of gallic acid equivalent/g d.w and 538 ± 1.4 mg of quercetinequivalent/g d.w, respectively. This higher content of total phenolics and flavonoids found in the ethanolic extract was directly associated to higher cytotoxicity activity.

conclusionThe ethanolic leaf gall extract of T. chebula showed effective cytotoxic activities; which might be attributed to the phenolics/flavonoids present in higher concentration. Future work will be interesting to know the chemical composition of the extract and also better understand the mechanism of action of the constituents present in the extract to develop it as drug for therapeutic application. SUMMARY: The present investigation establishes the anticancer activities of T. chebula leaf gall extracts on BRL3A, MCF-7, and A-549 cells. Presumably, these activities could be attributed in part to the phenolics/flavanoids features of the extract that has been demonstrated to act as cytotoxic agents. The experimental evidence obtained in the laboratory model could provide a rationale for the traditional use of plant as a source of easily available effective anticancer agents to the people, particularly in developing countries.

Indexed as

Alternative medicinedrugsindian medicinal plantsinhibitiontraditional medicine

Identifiers

PMID27365992
PMCPMC4908852

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.